Rivista in lingua italiana
riservata ai Soci SISA
Ultimo numero:
Anno 15 • N.4/2024
EAS Congress 2012 - Satellite Symposium
Updating in Apheresis and Atherosclerosis Research
7th LIPIDCLUB & Therapeutic Apheresis
San Gemini (TR), May 23-24, 2012
Wednesday May 23 - afternoon
SPECIAL SESSION ON THERAPEUTIC APHERESIS
Chairpersons: Andrea Mezzetti, Claudia Stefanutti
Why an apheresis center should not offer only one lipoprotein apheresis
method?
Ulrich Julius, Dresden
Pro-functional intervention for diabetic foot: position of LDL-apheresis
Kouichi Tamura, Yokohama
H.E.L.P.-apheresis effect on rheology, vasodilatation and oxidative stress
Klaus Peter Mellwig, Bad Oeynhausen
Discussion
Combining novel cholesterol-lowering drugs, HDL-cholesterol enhancers,
and LDL-apheresis
Claudia Stefanutti, Roma
Discussion
THE ITALIAN MULTICENTER STUDY ON LDL-APHERESIS WORKING GROUP - ROUND TABLE
Chairpersons: Andrea Mezzetti, Claudia Stefanutti
How the novel imaging techniques may help in cardiovascular risk profile
definition in high risk individuals
Stefano Bosi, Cotignola - Ravenna
Italian Multicenter Study for LDL-apheresis: the 2009 Survey
Claudia Morozzi, San Gemini
Severe hypertriglyceridemia-related acute pancreatitis
Giancarlo Labbadia, Roma
Discussion and 1st working day's conclusion
Thursday May 24
SPECIAL SESSION ON CARDIOVASCULAR RISK FACTORS
AND CORONARY ARTERY DISEASE PREVENTION.
TREATMENT OF METABOLIC DISEASES.
ATHEROSCLEROSIS.
Chairpersons: Francesco Angelico, Renato Fellin, Claudia Stefanutti
Lipoprotein(a) as a cause of atherosclerosis and related complications
Philip Haycock, Cambridge
Current ways of treating dyslipidemias to prevent atherosclerosis
Francesco Angelico, Roma
Perspectives of novel drugs for treatment of Dyslipidemias
LluÃs Masana MarÃn, Reus
Diagnosis and treatment of Dyslipidemia in children
Kurt Widhalm, Wien
Discussion
The 2011 American Heart Association and the 2011 EAS/ESC Guidelines for Prevention of Cardiovascular Disease in Women: the gynecologist's point of view
Giuseppina Perrone, Roma
Multi-modal imaging technologies in cardiovascular risk assessment
Gianfranco Gualdi, Roma
Discussion and conclusion
Chairmen
Francesco Angelico, Roma
Renato Fellin, Ferrara
Andrea Mezzetti, Chieti
Claudia Stefanutti, Roma
Faculty
Francesco Angelico, Roma
Stefano Bosi, Cotignola - Ravenna
Gianfranco Gualdi, Roma
Philip Haycock, Cambridge
Ulrich Julius, Dresden
Giancarlo Labbadia, Roma
LluÃs Masana MarÃn, Reus
Klaus Peter Mellwig, Bad Oeynhausen
Claudia Morozzi, San Gemini
Giuseppina Perrone, Roma
Claudia Stefanutti, Roma
Kouichi Tamura, Yokohama
Kurt Widhalm, Wien
Scientific Advisory and Seminary organization
Professor Claudia Stefanutti M.D.,Ph.D.
Head of Extracorporeal Therapeutic Techniques Unit
Immunohematology and Transfusion Medicine
Department of Molecular Medicine
University of Rome ”˜La Sapienza'
Umberto I' Hospital
155, V.le del Policlinico
Italian Multicenter Study on LDL-apheresis Working Group Coordinator
Outpatients' Atherosclerosis Clinic and Research Centre
V.le del Policlinico 155
I-00161 - Roma
Tel: +39 06 499 70578
Fax: +39 06 499 70141
Second address (Correspondence):
Via Chieti 7 - Roma
Tel: +39 06 499 76521
e-mail: claudia.stefanutti@uniroma1.it
Organizing Secretariat
Centro Italiano Congressi CIC
Corso Trieste, 42
00198 - Roma
Tel. +39 06 8412673
Fax +39 06 8412687
meetinglipidclub2012@gruppocic.it
www.centroitalianocongressi.it
Roma, 23-25 novembre 2025
Save the date
Rimini, 6-8 aprile 2025
[continua a leggere]Modena, 4-5 Luglio 2024
[continua a leggere]Rivista in lingua italiana
riservata ai Soci SISA
Ultimo numero:
Anno 15 • N.4/2024
Rivista Italiana della
Ipercolesterolemia
Familiare Omozigote
Anno 6 • N.1/2024
Nuovo sito dedicato al Progetto LIPIGEN
Progetto LIPIGEN - Vecchio portale
E' necessario essere loggati come utente
Lipigen per poter accedere alla pagina
PROSISA – PROject Statin Intolerance SISA
E' necessario essere loggati come utente
PROSISA per poter accedere alla pagina
Gruppo Interdisciplinare Lipoprotein Aferesi
(Accesso Gruppo GILA-Lipoprotein Aferesi)
E' necessario essere loggati come utente del Gruppo GILA per poter accedere
Gruppo Interdisciplinare Lipoprotein Aferesi
(Documentazione ad accesso libero)
Pagina informativa per medici e pazienti